Primary carcinomas of the liver /
edited by Hero K. Hussain, Isaac R. Francis.
- Cambridge : Cambridge University Press, 2010.
- 1 online resource (xi, 241 pages) : digital, PDF file(s).
- Contemporary issues in cancer imaging .
- Contemporary issues in cancer imaging. .
Title from publisher's bibliographic system (viewed on 05 Oct 2015).
Epidemiology of hepatocellular carcinoma and cholangiocarcinoma / Jorge A. Marrero -- Surveillance and screening for heptocellular carcinoma / Jorge A. Marrero, Hero K. Hussain -- Pathology of hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma / Barbara McKenna and Sharon Bihlmeyer -- Radiological diagnosis of hepatocellular carcinoma / Jonathon M. Willatt, Hero K. Hussain, and Isaac R. Francis -- Staging of hepatocellular carcinoma / Jorge A. Marerro and Hero K. Hussain -- Surgical treatment of hepatocellular carcinoma : resection and transplantation / Sean Kumer and Shawn J. Pelletier -- Non-surgical treatment of hepatocellular carcinoma -- Radiological identification of residual and recurrent hepatocellular carcinoma / Peter S. Liu, Ajaykumar C. Morani, and Hero K. Hussain -- Radiological diagnosis of cholangiocarcinoma / Hero K. Hussain and Isaac R. Francis -- Staging of cholangiocarcinoma / Hero K. Hussain and James A. Knol -- Treatment of cholangiocarcinoma -- Uncommon hepatic tumors / Peter S. Liu and Hero K. Hussain.
Primary carcinomas of the liver are increasing in incidence in the developed world, probably due to dietary and environmental factors as well as the known role of infective agents such as Hepatitis C. They are usually diagnosed in the advanced stages and carry high morbidity and mortality. This volume summarises the latest developments in imaging of primary hepatic carcinomas, emphasising the multidisciplinary approach to the care of patients. In addition to extensive chapters on the radiological issues surrounding diagnosis and staging of the malignancies, individual chapters on epidemiology, pathology, and surgical and non-surgical treatment options are included. All treatment options are considered for both HCC and cholangiocarcinoma, including newer techniques such as TACE. Only by a well orchestrated multidisciplinary team approach including epidemiologists, diagnostic radiologists, hepatologists, oncologic surgeons, radiation oncologists, and pathologists can these complex malignancies be managed successfully.